Electronic Product Information (ePI) has the potential to make authorised medicinal product information more than a static digital document. Structured and interoperable ePI can be searched, exchanged, and linked with trusted health data - helping make relevant information more accessible within real medication-use processes.

In a new thought-leadership article, Rote Liste considers how ePI could contribute to a patient-centred information landscape. When connected with electronic health records, medication plans, and other relevant data, structured information could support better-informed conversations and decisions among patients, physicians, and pharmacists. Particularly in complex situations such as polypharmacy, high-risk care, and transitions of care.

Read the full article from Rote Liste


Explore further ePI guidance and resources in the cormeo ePI Resource Hub.


whiteWaveTop

Latest Blog Posts

500

The Future of Patient Information: Beyond the Digital Leaflet

500

How AI Can Support Your Organization’s ePI Implementation

500

The Benefits of ePI for Patients

500

The Role of National Compendia to deliver trusted, Regulator approved electronic Product Information (ePI) across Boarders